As Adapt Pharma builds and grows, we are interested in collaborating with partners from around the globe. Our focus is on novel therapeutic medicines that can positively affect the lives of patients with specialty medical conditions. Currently, ADAPT markets NARCAN® Nasal Spray in the United States and Canada. The company is also researching and developing additional product candidates for opioid overdose and for the treatment of opioid addiction.
If you have an opportunity from mid-clinical development through the commercial stage, we welcome the opportunity to speak or meet with you. Please email or contact Adapt Pharma at: